All About Multiple Sclerosis

More MS news articles for January 2004

Researchers report possible link between Vitamin D intake and reduced risk of MS

http://www.nationalmssociety.org/Research-2004Jan12.asp

January 12, 2004
Research Programs Department
The National Multiple Sclerosis Society

Summary:

A new study in nurses suggests that those with higher vitamin D intake may have had a reduced risk of developing multiple sclerosis.

Details:

A new study in nurses suggests that those with higher vitamin D intake may have had a reduced risk of developing multiple sclerosis. Kassandra Munger, MSc, and colleagues (Harvard School of Public Health, University of California at Irvine) report their findings in the January 13, 2004 issue of Neurology.

Background:

The cause of multiple sclerosis, which involves immune attacks against the body’s own brain and spinal cord tissues, is unknown. Worldwide, MS occurs with much less frequency in lower latitudes closer to the equator, than in higher latitudes, further away from the equator. It is thought that there may be genetic, infectious, and environmental factors that increase or decrease an individual’s risk of developing MS. One of several possible “protective” factors at work in lower latitudes which are being explored is the increased sunlight exposure in these areas and the resulting increase in the body’s production of vitamin D.  Vitamin D is available not only through sun exposure but also from nutritional sources and vitamin supplementation.

In general, Vitamin D helps the body use calcium. In addition, immune cells have been shown to be influenced by vitamin D, and preliminary research suggests that vitamin D can alter immune attacks in mice with MS-like disease.

The Study:

To investigate the relation between vitamin D levels and the risk for developing MS, Dr. Munger’s team used the database from the Nurses’ Health Study I and Nurses Health Study II, which regularly surveys female registered nurses about their history of diseases and lifestyles. For this study, the investigators focused on dietary assessments from 187,563 of the participants. The study included 173 women diagnosed with probable or definite MS after their enrollment in the Study (between the ages of 30-55 for NHS I or 25-42 for NHS II). Vitamin D intake was determined through the Nurses’ Health Study questionnaire and four one-week diet records, which included queries about diet and use of dietary supplements. Blood levels of vitamin D were examined, and analyses were performed to determine other factors that might affect the results, such as latitude of the subject’s birthplace and smoking (members of this research group reported an increased risk of MS among nurses who smoked in the October 28, 2003 issue of Neurology).

Results:

Women whose intake of vitamin D was greater than or equal to about 400 IU/day (the amount usually contained in multivitamin supplements), from either supplements – mostly multivitamins – and food, or from supplements alone, had a 40% lower risk of developing MS than those women who did not take vitamin D supplements. No reduced risks were found for vitamin D intake from food alone. Further analyses of smoking habits and birthplace did not affect these results. There is no information in this study to determine whether vitamin D affects the course of MS once it has begun.

Importantly, vitamin D intake was strongly associated with intake of other components of multivitamins, including vitamins A and E and folic acid. Therefore, it was not possible for the group to analyze the effects of vitamin D intake independently from these other vitamins. The authors note that the strongest evidence to date implicates vitamin D, and suggest that this vitamin seems to be the most likely candidate for association with reduced risk of MS.

Conclusion:

This study adds new information to ongoing research focused on a possible role for vitamin D in reducing the risk of developing MS. Further research is necessary to clarify these findings, for example: What is the role of vitamin D versus other vitamins? Do these findings apply to men as well? Can vitamin D alter the course of existing MS?

The National MS Society is funding several researchers investigating the possible association of sunlight exposure, vitamin D and the risk of MS, including:

NOTE:

The U.S. government-issued “Adequate Intake” level of daily vitamin D for adults is 5-15 micrograms or 200-600 International Units, which includes the range of vitamin D intake that seemed beneficial in this study. Excessive intake of supplemental vitamin D can have serious, toxic effects on the body, including excessive calcium levels in the blood, high blood pressure, nausea, anorexia, impaired kidney function and kidney damage.
 

Copyright © 2004, The National Multiple Sclerosis Society